APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alimta

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Alimta Market Outlook and Growth Opportunities 2026

22 December 2025191 pages

Choose your research edition.

Industry ResearchAlimta Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Alimta Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Alimta Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alimta Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Alimta Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Alimta market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Alimta is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Alimta is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alimta is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Alimta market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Alimta market include Eagle Pharmaceuticals, Eli Lilly, Cadila Healthcare and Abbott Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Alimta market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Alimta and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alimta sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alimta market size, projected growth trends, production technologies, key applications, and end-use industries.

Alimta Segment by Company

Eagle Pharmaceuticals

Eli Lilly

Cadila Healthcare

Abbott Healthcare

Alimta Segment by Type

100mg

500mg

Alimta Segment by Application

Pleural Mesothelioma

Non-small Cell Lung Cancer

Alimta Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Alimta status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Alimta market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Alimta significant trends, drivers, influence factors in global and regions.

6. To analyze Alimta competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alimta market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alimta and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alimta.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Alimta market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Alimta industry.

Chapter 3: Detailed analysis of Alimta manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Alimta in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Alimta in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Alimta Industry Trends Table 2. Alimta Industry Drivers Table 3. Alimta Industry Opportunities and Challenges Table 4. Alimta Industry Restraints Table 5. Global Alimta Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Alimta Revenue Share by Company (2021-2026) Table 7. Global Alimta Sales Volume by Company (kg) & (2021-2026) Table 8. Global Alimta Sales Volume Share by Company (2021-2026) Table 9. Global Alimta Average Price (US$/g) of Company (2021-2026) Table 10. Global Alimta Company Ranking, (2024-2026) & (USD Million) Table 11. Global Alimta Key Company Manufacturing Base & Headquarters Table 12. Global Alimta Company, Product Type & Application Table 13. Global Alimta Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Alimta by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 100mg Table 18. Significant Companies of 500mg Table 19. Global Alimta Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 20. Global Alimta Sales Volume by Type (2021-2026) & (kg) Table 21. Global Alimta Sales Volume by Type (2027-2032) & (kg) Table 22. Global Alimta Sales Volume Share by Type (2021-2026) Table 23. Global Alimta Sales Volume Share by Type (2027-2032) Table 24. Global Alimta Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Alimta Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Alimta Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Alimta Sales Value Share by Type (2021-2026) Table 28. Global Alimta Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Pleural Mesothelioma Table 30. Significant Companies of Non-small Cell Lung Cancer Table 31. Global Alimta Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 32. Global Alimta Sales Volume by Application (2021-2026) & (kg) Table 33. Global Alimta Sales Volume by Application (2027-2032) & (kg) Table 34. Global Alimta Sales Volume Share by Application (2021-2026) Table 35. Global Alimta Sales Volume Share by Application (2027-2032) Table 36. Global Alimta Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Alimta Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Alimta Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Alimta Sales Value Share by Application (2021-2026) Table 40. Global Alimta Sales Value Share by Application (2027-2032) Table 41. Global Alimta Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 42. Global Alimta Sales by Region (2021-2026) & (kg) Table 43. Global Alimta Sales Market Share by Region (2021-2026) Table 44. Global Alimta Sales by Region (2027-2032) & (kg) Table 45. Global Alimta Sales Market Share by Region (2027-2032) Table 46. Global Alimta Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Alimta Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Alimta Sales Value Share by Region (2021-2026) Table 49. Global Alimta Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Alimta Sales Value Share by Region (2027-2032) Table 51. Global Alimta Market Average Price (US$/g) by Region (2021-2026) Table 52. Global Alimta Market Average Price (US$/g) by Region (2027-2032) Table 53. Global Alimta Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 54. Global Alimta Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Alimta Sales by Country (2021-2026) & (kg) Table 56. Global Alimta Sales Market Share by Country (2021-2026) Table 57. Global Alimta Sales by Country (2027-2032) & (kg) Table 58. Global Alimta Sales Market Share by Country (2027-2032) Table 59. Global Alimta Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Alimta Sales Value Market Share by Country (2021-2026) Table 61. Global Alimta Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Alimta Sales Value Market Share by Country (2027-2032) Table 63. Eagle Pharmaceuticals Company Information Table 64. Eagle Pharmaceuticals Business Overview Table 65. Eagle Pharmaceuticals Alimta Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 66. Eagle Pharmaceuticals Alimta Product Portfolio Table 67. Eagle Pharmaceuticals Recent Development Table 68. Eli Lilly Company Information Table 69. Eli Lilly Business Overview Table 70. Eli Lilly Alimta Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 71. Eli Lilly Alimta Product Portfolio Table 72. Eli Lilly Recent Development Table 73. Cadila Healthcare Company Information Table 74. Cadila Healthcare Business Overview Table 75. Cadila Healthcare Alimta Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 76. Cadila Healthcare Alimta Product Portfolio Table 77. Cadila Healthcare Recent Development Table 78. Abbott Healthcare Company Information Table 79. Abbott Healthcare Business Overview Table 80. Abbott Healthcare Alimta Sales (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 81. Abbott Healthcare Alimta Product Portfolio Table 82. Abbott Healthcare Recent Development Table 83. Key Raw Materials Table 84. Raw Materials Key Suppliers Table 85. Alimta Distributors List Table 86. Alimta Customers List Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. Alimta Product Image Figure 2. Global Alimta Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alimta Sales Value (2021-2032) & (US$ Million) Figure 4. Global Alimta Sales (2021-2032) & (kg) Figure 5. Global Alimta Sales Average Price (US$/g) & (2021-2032) Figure 6. Global Alimta Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 100mg Image Figure 10. 500mg Image Figure 11. Global Alimta Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 12. Global Alimta Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Alimta Sales Volume Share by Type (2021-2032) Figure 14. Global Alimta Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Alimta Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Alimta Sales Value Share by Type (2021-2032) Figure 17. Pleural Mesothelioma Image Figure 18. Non-small Cell Lung Cancer Image Figure 19. Global Alimta Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 20. Global Alimta Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Alimta Sales Volume Share by Application (2021-2032) Figure 22. Global Alimta Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Alimta Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Alimta Sales Value Share by Application (2021-2032) Figure 25. Global Alimta Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 26. Global Alimta Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Alimta Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Alimta Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Alimta Sales Value (2021-2032) & (US$ Million) Figure 30. North America Alimta Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Alimta Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Alimta Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Alimta Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Alimta Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Alimta Sales Value (2021-2032) & (US$ Million) Figure 36. South America Alimta Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Alimta Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Alimta Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Alimta Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Alimta Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Alimta Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Alimta Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Alimta Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg
  • 500mg
Applications
  • Pleural Mesothelioma
  • Non-small Cell Lung Cancer
Companies covered
  • Eagle Pharmaceuticals
  • Eli Lilly
  • Cadila Healthcare
  • Abbott Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alimta Sales Value (2021-2032)
  4. 1.2.2 Global Alimta Sales Volume (2021-2032)
  5. 1.2.3 Global Alimta Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Alimta Market Dynamics
  1. 2.1 Alimta Industry Trends
  2. 2.2 Alimta Industry Drivers
  3. 2.3 Alimta Industry Opportunities and Challenges
  4. 2.4 Alimta Industry Restraints
3 Alimta Market by Company
  1. 3.1 Global Alimta Company Revenue Ranking in 2025
  2. 3.2 Global Alimta Revenue by Company (2021-2026)
  3. 3.3 Global Alimta Sales Volume by Company (2021-2026)
  4. 3.4 Global Alimta Average Price by Company (2021-2026)
  5. 3.5 Global Alimta Company Ranking (2024-2026)
  6. 3.6 Global Alimta Company Manufacturing Base and Headquarters
  7. 3.7 Global Alimta Company Product Type and Application
  8. 3.8 Global Alimta Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Alimta Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Alimta Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Alimta Market by Type
  1. 4.1 Alimta Type Introduction
  2. 4.1.1 100mg
  3. 4.1.2 500mg
  4. 4.2 Global Alimta Sales Volume by Type
  5. 4.2.1 Global Alimta Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Alimta Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Alimta Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Alimta Sales Value by Type
  9. 4.3.1 Global Alimta Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Alimta Sales Value by Type (2021-2032)
  11. 4.3.3 Global Alimta Sales Value Share by Type (2021-2032)
5 Alimta Market by Application
  1. 5.1 Alimta Application Introduction
  2. 5.1.1 Pleural Mesothelioma
  3. 5.1.2 Non-small Cell Lung Cancer
  4. 5.2 Global Alimta Sales Volume by Application
  5. 5.2.1 Global Alimta Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Alimta Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Alimta Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Alimta Sales Value by Application
  9. 5.3.1 Global Alimta Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Alimta Sales Value by Application (2021-2032)
  11. 5.3.3 Global Alimta Sales Value Share by Application (2021-2032)
6 Alimta Regional Sales and Value Analysis
  1. 6.1 Global Alimta Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alimta Sales by Region (2021-2032)
  3. 6.2.1 Global Alimta Sales by Region: 2021-2026
  4. 6.2.2 Global Alimta Sales by Region (2027-2032)
  5. 6.3 Global Alimta Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Alimta Sales Value by Region (2021-2032)
  7. 6.4.1 Global Alimta Sales Value by Region: 2021-2026
  8. 6.4.2 Global Alimta Sales Value by Region (2027-2032)
  9. 6.5 Global Alimta Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Alimta Sales Value (2021-2032)
  12. 6.6.2 North America Alimta Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Alimta Sales Value (2021-2032)
  15. 6.7.2 Europe Alimta Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Alimta Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Alimta Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Alimta Sales Value (2021-2032)
  21. 6.9.2 South America Alimta Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Alimta Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Alimta Sales Value Share by Country, 2025 VS 2032
7 Alimta Country-level Sales and Value Analysis
  1. 7.1 Global Alimta Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Alimta Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Alimta Sales by Country (2021-2032)
  4. 7.3.1 Global Alimta Sales by Country (2021-2026)
  5. 7.3.2 Global Alimta Sales by Country (2027-2032)
  6. 7.4 Global Alimta Sales Value by Country (2021-2032)
  7. 7.4.1 Global Alimta Sales Value by Country (2021-2026)
  8. 7.4.2 Global Alimta Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Alimta Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Alimta Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Alimta Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Alimta Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Alimta Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Alimta Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Alimta Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Alimta Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Alimta Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Alimta Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Alimta Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Alimta Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Alimta Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Alimta Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Alimta Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Alimta Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Alimta Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Alimta Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Alimta Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Alimta Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Alimta Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Alimta Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Alimta Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Alimta Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Alimta Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Alimta Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Alimta Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Alimta Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Alimta Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Alimta Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Alimta Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Alimta Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Alimta Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Alimta Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Alimta Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Alimta Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Alimta Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Alimta Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Alimta Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Alimta Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Alimta Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Alimta Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Alimta Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Alimta Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Alimta Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Alimta Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Alimta Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Alimta Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Alimta Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Alimta Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Alimta Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Alimta Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Alimta Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Alimta Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Alimta Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Alimta Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Alimta Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Alimta Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Alimta Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Alimta Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Alimta Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Alimta Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Alimta Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Alimta Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Alimta Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Alimta Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Alimta Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Alimta Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Alimta Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Alimta Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Alimta Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Alimta Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Alimta Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Alimta Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Alimta Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Alimta Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Alimta Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Alimta Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Alimta Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Alimta Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Alimta Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Alimta Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Alimta Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Alimta Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eagle Pharmaceuticals
  2. 8.1.1 Eagle Pharmaceuticals Company Information
  3. 8.1.2 Eagle Pharmaceuticals Business Overview
  4. 8.1.3 Eagle Pharmaceuticals Alimta Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Eagle Pharmaceuticals Alimta Product Portfolio
  6. 8.1.5 Eagle Pharmaceuticals Recent Developments
  7. 8.2 Eli Lilly
  8. 8.2.1 Eli Lilly Company Information
  9. 8.2.2 Eli Lilly Business Overview
  10. 8.2.3 Eli Lilly Alimta Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly Alimta Product Portfolio
  12. 8.2.5 Eli Lilly Recent Developments
  13. 8.3 Cadila Healthcare
  14. 8.3.1 Cadila Healthcare Company Information
  15. 8.3.2 Cadila Healthcare Business Overview
  16. 8.3.3 Cadila Healthcare Alimta Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cadila Healthcare Alimta Product Portfolio
  18. 8.3.5 Cadila Healthcare Recent Developments
  19. 8.4 Abbott Healthcare
  20. 8.4.1 Abbott Healthcare Company Information
  21. 8.4.2 Abbott Healthcare Business Overview
  22. 8.4.3 Abbott Healthcare Alimta Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Abbott Healthcare Alimta Product Portfolio
  24. 8.4.5 Abbott Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Alimta Value Chain Analysis
  2. 9.1.1 Alimta Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Alimta Sales Mode & Process
  6. 9.2 Alimta Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Alimta Distributors
  9. 9.2.3 Alimta Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst